Medical Xpress news

Medical Xpress / Gene scissors in camouflage mode help in the search for cancer therapies

The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer research in mouse models with an immune system that is as natural as possible—which is easier said ...

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / Expert argues psychedelics too unruly for traditional product development

Investor appetite in corporate psychedelia is returning, but the sector faces fundamental barriers to profitability, according to new research.

Nov 20, 2025 in Medications
Medical Xpress / Scientists use stem cells to model rare genetic blindness in children

Researchers at the Eye Genetics Research Unit at Children's Medical Research Institute (CMRI) are the first in the world to use stem cells to study one of the genetic causes of Leber Congenital Amaurosis (LCA)—a rare condition ...

Nov 20, 2025 in Ophthalmology
Medical Xpress / Decoding real-life fear for precision social anxiety treatments

Researchers at The University of Hong Kong (HKU) have unveiled a transformative approach to understanding and treating social anxiety, challenging decades of laboratory-based assumptions and opening doors to targeted therapies.

Nov 20, 2025 in Psychology & Psychiatry
Medical Xpress / Everyday routines in early infancy may shape later obesity risk

In the United States, approximately 14.7 million children and adolescents between the ages of 2 and 19 are living with obesity, according to the Centers for Disease Control and Prevention. Since children living with obesity ...

Nov 20, 2025 in Overweight & Obesity
Medical Xpress / Clinical tool helps predict which brain tumors will require treatment

A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately predict whether the most common type of brain tumor will grow or cause symptoms, helping doctors and ...

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / Long-term pharmacological treatment shows promise against memory impairments in Down syndrome

In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, described that mice models for Down syndrome have more cannabinoid receptor 1 (CBR1) in some regions ...

Medical Xpress / Gene variant increases brain inflammation in those with repetitive head impacts

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease caused by repetitive head impacts (RHI). However, individuals with similar RHI exposure have shown differing pathology, suggesting a role for genetic variation. ...

Nov 20, 2025 in Genetics
Medical Xpress / Order of genetic mutations shapes cancer's development and patient outcomes

In many aspects of our lives, we find meaning in the order in which events occur. We buy into myths about "middle child syndrome," talk of calm before storms, and consider it strange to start a meal with dessert.

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / A microRNA cocktail weakens brain tumors in preclinical trials

A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous system, such as glioblastoma.

Nov 20, 2025 in Oncology & Cancer
Medical Xpress / How AI can create a virtual programmable human and revolutionize drug discovery

From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely succeeds.

Nov 20, 2025 in Medications
Medical Xpress / How machine learning can help optimize treatment for septic shock

A multi-institutional research team has demonstrated how AI and machine learning can optimize therapy selection and dosing for septic shock, a life-threatening complication that is the leading cause of hospital deaths.